Teva Pharmaceutical Industries Limited (TEV) — Long-term Investment Intensity
Teva Pharmaceutical Industries Limited (TEV) has a Long-term Investment Intensity of 0.1% as of December 2018. Long-term investments of €61.00 Million represent 0.1% of total assets of €60.68 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See TEV net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Teva Pharmaceutical Industries Limited Long-term Investment Intensity (2015–2018)
This chart shows how Teva Pharmaceutical Industries Limited's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of December 2018, the intensity stands at 0.1%, reflecting long-term investments of €61.00 Million against total assets of €60.68 Billion EUR. Also explore Teva Pharmaceutical Industries Limited asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Teva Pharmaceutical Industries Limited (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Teva Pharmaceutical Industries Limited from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Teva Pharmaceutical Industries Limited (TEV) total market value.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | €61.00 Million | €60.68 Billion | ▼ 0.0 pp |
| 2017 | 0.1% | €83.00 Million | €70.61 Billion | ▼ -0.2 pp |
| 2016 | 0.3% | €283.00 Million | €92.89 Billion | ▼ -2.4 pp |
| 2015 | 2.7% | €1.45 Billion | €54.23 Billion | — |